Can nebulised HepArin Reduce morTality and time to Extubation in patients with COVID‐19 Requiring invasive ventilation Meta‐Trial (CHARTER‐MT): Protocol and statistical analysis plan for an investigator‐initiated international meta‐trial of prospective randomised clinical studies-Reference-Cited by-同舟云学术

Can nebulised HepArin Reduce morTality and time to Extubation in patients with COVID‐19 Requiring invasive ventilation Meta‐Trial (CHARTER‐MT): Protocol and statistical analysis plan for an investigator‐initiated international meta‐trial of prospective randomised clinical studies

Published:2022-02-20 Issue:7 Volume:88 Page:3272-3287
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit J Clinical Pharma

Author:

van Haren Frank M. P.¹²³^ORCID,Laffey John G.⁴⁵^ORCID,Artigas Antonio⁶,Page Clive⁷,Schultz Marcus J.⁸⁹¹⁰,Cosgrave David⁵,McNicholas Bairbre⁵,Smoot Thomas L.¹¹^ORCID,Nunes Quentin¹²,Richardson Alice¹,Yoon Hwan‐Jin¹,van Loon Lex M.¹,Ghosh Angajendra¹³,Said Simone¹³,Panwar Rakshit¹⁴,Smith Roger¹⁵,Santamaria John D.¹⁵,Dixon Barry¹⁵,

Affiliation:

1. Australian National University Canberra Australia

2. University of New South Wales Sydney Australia

3. Intensive Care Unit, St George Hospital Sydney Australia

4. Anaesthesia and Intensive Care Medicine, School of Medicine, and Regenerative Medicine Institute (REMEDI) at CÚRAM Centre for Research in Medical Devices, Biomedical Sciences Building National University of Ireland Galway Galway Ireland

5. Department of Anaesthesia, University Hospital Galway Saolta Hospital Group Ireland

6. Critical Center, Corporació Sanitaria Parc Tauli, CIBER Enfermedades Respiratorias Autonomous University of Barcelona Sabadell Spain

7. Sackler Institute of Pulmonary Pharmacology King's College London UK

8. Department of Intensive Care Amsterdam University Medical Centre Amsterdam the Netherlands

9. Nuffield Department of Medicine Oxford University Oxford UK

10. Mahidol‐Oxford Tropical Medicine Research Unit Mahidol University Bangkok Thailand

11. Frederick Memorial Hospital Frederick Maryland USA

12. Institute of Systems, Molecular and Integrative Biology University of Liverpool Liverpool UK

13. Intensive Care Unit, The Northern Hospital Melbourne Australia

14. John Hunter Hospital Newcastle Australia

15. Department of Critical Care Medicine St Vincent's Hospital Melbourne Australia

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.15253

Reference37 articles.

1. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

2. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy

3. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China

4. Acute Respiratory Distress Syndrome

5. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nebulized enriched heparin improves respiratory parameters in patients with COVID-19: a phase I/II randomized and triple-blind clinical trial;Scientific Reports;2024-08-27

2. Experience in the use of non-immunogenic recombinant staphylokinase in the treatment of massive pulmonary embolism;Meditsinskiy sovet = Medical Council;2024-05-20

3. Exploring the therapeutic role of early heparin administration in ARDS management: a MIMIC-IV database analysis;Journal of Intensive Care;2024-02-26

4. Experience in the treatment of patients with pulmonary embolism using apixaban and ultrasound inhalations of unfractionated heparin;Meditsinskiy sovet = Medical Council;2023-05-03

5. Heparin, Low Molecular Weight Heparin, and Non-Anticoagulant Derivatives for the Treatment of Inflammatory Lung Disease;Pharmaceuticals;2023-04-13